Zhonghua Gan Zang Bing Za Zhi
April 2014
Objective: To study the correlation between clinically detected serum galectin-3 levels and prognosis of liver failure.
Methods: Fifty-five patients diagnosed with liver failure were administered a combined modality therapy and followed up until death or for 6 months. Fifty-five patients with liver failure were administered a combined modality therapy and followed up until death or for 6 months.